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AbsTrACT
Objectives Trichomoniasis is the most prevalent 
curable STI globally, with the highest incidence and 
prevalence in sub-Saharan Africa (sSA). STIs have largely 
been associated with an increase in HIV acquisition. Our 
objective was to assess the existing literature available in 
English regarding the association of Trichomoniasis and 
HIV-1 acquisition.
Methods The review protocol was registered at the 
International Prospective Register of Systematic Reviews 
(PROSPERO) under number CRD42018082702. We 
searched MEDLINE, Embase and Scopus databases to 
collect articles measuring the association of Trichomonas 
vaginalis infection and HIV acquisition and performed a 
meta-analysis and qualitative synthesis of the literature.
results We identified 1806 unduplicated citations, 
of which 18 papers and 1 conference abstract were 
eligible for inclusion in the review after applying our 
inclusion and exclusion criteria. All the studies included 
in the systematic review had been carried out in sSA. 
The articles reported various measures of effects, namely: 
HRs, rate ratios, risk ratios and ORs. In a meta-analysis 
restricted to 11 studies reporting HR, individuals infected 
with T. vaginalis were 1.5 times more likely to acquire 
HIV compared with individuals not infected with T. 
vaginalis (95% CI 1.3 to 1.7; p<0.001).
Conclusions T. vaginalis is an important factor in HIV 
acquisition especially in sSA where the prevalence of 
both T. vaginalis and HIV-1 are high. This systematic 
review and meta-analysis confirms the evidence that 
infection with T. vaginalis augments HIV acquisition with 
50%. Diagnosis and treatment of T. vaginalis infection 
in both high-risk and low-risk individuals may be a 
potential tool to reduce new HIV infections.
Trial registration number CRD42018082702
InTrOduCTIOn
The protozoan Trichomonas vaginalis is responsible 
for trichomoniasis, the most common curable STI.1 
T. vaginalis infects both men and women, although 
this unicellular parasite is more prevalent in women 
than men. Among people aged 15–49 years, it was 
estimated that in 2012 the global prevalence of T. 
vaginalis infection among women was 5.0% versus 
0.6% among men. These figures correspond to an 
estimated incidence of 143 million newly infected 
individuals.1 Similar to HIV, T. vaginalis is more 
prevalent in sub-Saharan Africa (sSA), as the cumu-
lative prevalence was estimated to be 11.5% among 
women aged between 15 years and 49 years in sSA 
in 2012.1
According to The Joint United Nations 
Programme on HIV and AIDS,2 about 5000 new 
HIV infections occurred daily in 2016, with a 
huge proportion, that is, 64%, of new infections 
occurring in sSA. Already two decades ago, reports 
suggested that individuals infected with T. vaginalis 
were at an increased risk of HIV acquisition.3 Some 
studies have also indicated that T. vaginalis and HIV 
coinfection increases genital shedding of HIV,4 but 
opinions differ, especially in the context of antiret-
roviral therapy.5 In summary, there is growing 
evidence that there is a need for special treatment 
considerations for T. vaginalis among women with 
HIV coinfection.6
Better understanding of the association T. 
vaginalis and HIV may provide insights on HIV 
infections that may be attributed to T. vaginalis. 
Moreover, we may learn how control of T. vagi-
nalis may impact HIV transmission as a potentially 
cost-effective strategy for reducing HIV transmis-
sion, particularly in regions where T. vaginalis is 
common.7 The objective of this systematic review 
and meta-analysis was to clarify the extent to which 
T. vaginalis infection is associated with HIV infec-
tion and acquisition.
MeThOds
Protocol and registration
We followed the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines8 for carrying out and reporting this 
systematic review and meta-analysis, using an a 
priori defined protocol.
eligibility criteria
We included studies that reported both T. vaginalis 
infection status and HIV status. We only included 
studies written in English and that documented 
OR, or risk ratio (RiR), or HRs, or provided the 
absolute numbers for these parameters to be calcu-
lated. There were no restrictions in terms of study 
design or geographical area where the studies were 
conducted. We included papers that were published 
up to 11 March 2018.
Reviews, narrative-only conference abstracts, 
comments, guidelines, case reports or case series, 
unpublished articles, multiple reports of the same 
data and in vitro and animal studies were not consid-
ered for inclusion. Infection with T. vaginalis was 
defined as the presence of the pathogen as assessed 
by culture, wet mount or molecular methods, while 
HIV status was defined by the presence of HIV anti-
bodies, HIV proteins, HIV RNA or DNA.
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Figure 1 Identification of studies included in the systematic review. HIV, human immunodefeciency virus; TV, Trichomonas vaginalis
search strategy
We searched Embased, MEDLINE (through PubMed) and 
Scopus. We used the combination of all of the following search 
terms (Trichomonas vaginalis, T. vaginalis and trichomoniasis) 
with all of the following search terms (AIDS, acquired immu-
nodeficiency syndrome, HIV, HIV, HIV-1 and HIV-2). The 
bibliographic references of the studies that were considered 
eligible were also hand searched.
study selection
Similar to the systematic review by Cools et al,9 studies were 
selected in a two-stage process (figure 1). First, all bibliographic 
references were screened to identify studies for full-text eval-
uation by one reviewer (SCM), on the basis of only the infor-
mation present in the title and abstract. Subsequently, the full 
texts of those articles not excluded in the screening process were 
assessed for eligibility, using the aforementioned criteria, by two 
authors independently (SCM and PC). Reasons for exclusion 
were recorded and categorised, and disagreements were resolved 
by consensus.
Using all search terms, searches were conducted for relevant 
papers in the preidentified databases (Embase, PubMed and 
Scopus), and from this, we identified 3398 papers. Once the 
search was completed, all of the retrieved articles were imported 
into EndNote X7.8 for removal of duplicates.
data collection process
A predefined data extraction form was pilot-tested and used 
for data extraction. From the 19 studies included in the system-
atic review and meta-analysis, the following information was 
collected: authors, year of publication, journal, country where 
the study had been carried out, study design, sample collection 
period, study population, mean/median age of the participants, 
total number of study participants, total number of samples 
included in the analysis, T. vaginalis detection method, assess-
ment of HIV status, relevant measures of effects or absolute 
numbers and statistics. This procedure was performed inde-
pendently by two authors (SCM and PC), and disagreements 
were resolved by discussion between both authors.
risk of bias in individual studies
To assess the quality and risk of bias of the included studies, we 
developed a quality appraisal tool (online supplementary table 
1) based on the Newcastle-Ottawa Scale.10 We adapted this tool 
to the content of our meta-analysis. Stars were assigned by SCM 
for three broad criteria (representativeness of the study groups, 
comparability of the study groups and quality of the outcome 
assessment) in order to provide a measure of their quality.
Studies that scored none or one, two or three stars for internal 
validity of representativeness were classified as having respec-
tively a high, medium or low risk of bias for this criterion. 
 o
n
 22 O
ctober 2018 by guest. Protected by copyright.
http://sti.bmj.com/
Sex Transm
 Infect: first published as 10.1136/sextrans-2018-053713 on 19 O
ctober 2018. Downloaded from
 
3Masha SC, et al. Sex Transm Infect 2018;0:1–7. doi:10.1136/sextrans-2018-053713
review
Studies assigned none, one or two stars for comparability or 
outcome were considered to have respectively a high, medium 
or low risk of bias for comparability and outcome.9
data analysis
The meta-analyses was performed using STATA V.13.1. We 
reported the results of the meta-analyses obtained after pooling 
individual study estimates with random effects model as HRs 
with 95% CI. The degree of heterogeneity between the studies 
was assessed using the I2 index, with percentages 25%, 50% and 
75% being indicative of low, moderate and high heterogeneity, 
respectively.11
To assess publication bias, a funnel plot was created by plot-
ting the natural logarithm of the HRs against the inverse of the 
SE. The symmetry of the funnel plots was visually inspected and 
statistically checked using Egger’s regression test.12
resulTs
Manuscript and study selection
A total of 1806 unduplicated citations were identified; we 
selected 164 abstracts for full-text evaluation (figure 1). There 
were 19 studies that met our inclusion criteria to be included in 
our systematic review.
description of selected studies
All studies were conducted in sSA, namely Burkina Faso (n=1), 
Democratic Republic of Congo (n=2), Ivory Coast (n=1), 
Kenya (n=5), Malawi (n=1), South Africa (n=4), Uganda 
(n=4), Zambia (n=1) and Zimbabwe (n=3). Some of the studies 
were conducted in more than one country. Of the included 19 
studies, 17 were cohorts and 2 were nested case–control studies. 
Generally, all these studies involved a baseline T. vaginalis test 
and additional testing performed at varying intervals depending 
on the study, with treatment for participants testing positive for 
T. vaginalis.
Thirteen of the studies found a positive association between T. 
vaginalis infection and HIV acquisition.
Eleven studies reported HRs of HIV acquisition in relation 
to T. vaginalis infection, three reported RRs (ie, comparison of 
incidence rates) of HIV acquisition in relation to T. vaginalis, 
two studies reported RiRs of HIV acquisition in relation to T. 
vaginalis and three reported ORs of HIV acquisition in relation 
to T. vaginalis (table 1).
Most studies (63%) had been carried out among high-risk 
individuals, that is, female sex workers, and serodiscordant 
couples. The rest of the studies (37%) had been carried out 
among low-risk populations, including women attending 
prenatal or postnatal clinics and family planning clinics and indi-
viduals from the general population. Only three studies had male 
participants. Direct microscopy was the most common method 
used for detection of T. vaginalis (73%) in the studies. Detection 
of HIV antibodies was the most common method used to deter-
mine HIV status (84%) in the studies (table 1).
Treatment of T. vaginalis in the studies included in the 
meta-analysis was mostly on the basis of metronidazole. 
However, not all participants infected with T. vaginalis received 
treatment. For instance, in the study by Van Der Pol et al13 , 
participants diagnosed using microscopy received treatment, 
while those diagnosed using nucleic acid amplification test 
(NAAT) were not treated. Additionally, in the study by Klein-
schmidt et al14 syndromic treatment of STIs was offered.
risk of bias within studies
Following the critical appraisals of the included studies (online 
supplementary figure 1). Fourteen studies were assessed as 
having a high risk of bias for representativeness (high-risk indi-
viduals, that is, female sex workers, and serodiscordant couples), 
three as having a medium risk of bias for representativeness 
(prenatal care clinic/postnatal care clinic women and family 
planning clinic attendees) and two studies as having a low risk 
of bias for representativeness (women from the general popu-
lation). For the risk of bias for outcome assessment, it was high 
for 1 study, medium for 16 studies and low for 2 studies. Eight 
out of the 19 studies were assessed as having a medium risk of 
bias for comparability, while 11 studies had a low risk of bias for 
comparability. Individual study appraisals are captured in online 
supplementary table 2.
Visual inspection of the funnel plot shows symmetrical distri-
bution of studies, suggesting no publication bias (figure 2), which 
is supported by Egger’s regression intercept (0.6; 95% CI −0.64 
to 1.82; p=0.304).
Association of T. vaginalis and hIV acquisition
Eleven of the studies that were reporting HR provided data for 
the meta-analysis. The point estimate for the HR ranged from 
0.71 to 4.79 (table 1). Bearing in mind that ORs and RRs measure 
only the number of events and take not into account when they 
occur, these two measures are appropriate for measuring dichot-
omous outcomes but less appropriate for analysing time-to-event 
outcomes, which is important when relating T. vaginalis infec-
tion and HIV acquisition. The meta-analysis indicated that indi-
viduals infected with T. vaginalis were 1.5 times more likely to 
acquire HIV as compared with individuals not infected with T. 
vaginalis (HR: 1.5; 95% CI 1.3 to 1.7; p<0.001) (figure 3).
dIsCussIOn
In this systematic review and meta-analysis, we assessed the 
extent to which T. vaginalis infection is associated with HIV 
acquisition. There has been a global decline in deaths from HIV/
AIDS-related causes, from a peak of 1.9 million in 2005 to 1.0 
million in 2016.2 Despite this, AIDS-related illnesses remain 
the leading cause of death among women of reproductive age 
(15–49 years) globally2 and the second leading cause of death 
for young women aged 15–24 years in sSA.2 The prevalence of 
T. vaginalis was estimated to be approximately 11% in 2012 
among women in sSA.1
Studies included in our meta-analysis had no heterogeneity 
and thus appropriate to be combined in a meta-analysis where 
we demonstrate that individuals infected with T. vaginalis are at 
a higher risk of HIV acquisition. T. vaginalis augments the like-
lihood of HIV acquisition by 50% (HR 1.5; 95% CI 1.3 to 1.7); 
the amount of HIV acquisition attributable to this pathogen 
(attributable risk) and its contribution to the HIV pandemic 
may be substantial due to the high prevalence of T. vaginalis 
infection, especially in sSA. Our results are in agreement with a 
previous systematic review where they also show infection with 
T. vaginalis increased risk of HIV acquisition.15
In a study where they included both high-risk individuals and 
low-risk individuals, the adjusted HR for HIV acquisition for 
women with T. vaginalis were higher in the low-risk individuals, 
suggesting that for women with less risk from sexual networks, 
infection with T. vaginalis infection is a very important risk 
factor for HIV acquisition.13
Most studies included in this systematic review used direct 
microscopy for detection of T. vaginalis, a diagnostic technique 
that has been shown to have a low sensitivity.13 In a study where 
they included both high-risk individuals and low-risk individ-
uals, the adjusted HR for HIV acquisition for women with T. 
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Figure 2 Funnel plot to assess publication bias among studies evaluating the association between Trichomonas vaginalis infection and HIV 
infection acquisition. The triangles represent the estimates of the 11 included studies of the association between T. vaginalis infection and HIV 
infection acquisition. The log of the HR is plotted on the horizontal axis, against the inverse of the SE of the HR on the vertical axis. The vertical line in 
the funnel plot indicates the fixed-effects summary estimate and the sloping lines indicate the expected 95% CIs for a given SE.
Figure 3 Forest plot of estimates of association between trichomoniasis and HIV acquisition. Studies are plotted to start with the one with the 
least weight. Each study is represented by a black circle and a horizontal line, which correspond to the HR and 95% CI, respectively. The area of the 
grey box around each study reflects the weight of the study (determined by random effects analysis) in the meta-analysis. The vertical line in the 
middle corresponds to an HR of 1.0. The diamond represents the overall HR with the 95% CI given by its width. The arrow indicates the study with the 
highest confidence interval.There was low heterogeneity of studies included in the meta-analysis as shown by the I2=0.0%, p=0.510.
vaginalis were higher in the low-risk individuals, suggesting that 
for women with less risk from sexual networks, infection with 
T. vaginalis infection is a very important risk factor for HIV.13
Several T. vaginalis pathogenic mechanisms of T. vaginalis 
may help to explain why individuals infected with T. vaginalis 
may be at a higher risk of HIV acquisition. First, T. vaginalis 
may damage the epithelial membranew2, which acts as a barrier 
to HIV through several pathogenic mechanisms; its cell-to-cell 
adhesionw3, haemolysisw4 and/or excretion of soluble factorsw5. 
Second, T. vaginalis has been shown to elicit an inflammatory 
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Key messages
 ► Trichomoniasis augments the likelihood of HIV acquisition by 
50%.
 ► Trichomoniasis may be an important factor in HIV acquisition 
especially in sub-Saharan Africa where the prevalence of both 
are high.
 ► Screening and treatment of trichomoniasis may be a 
potential means of curbing new HIV infections among 
women with high-risk or moderate-risk behaviour.
response among infected individuals this may lead to an increase 
in the appearance of HIV target cellsw6,w7. Third, infection 
with T. vaginalis has been associated with bacterial vaginosisw8 
which, in turn, can increase the risk of HIV acquisitionw9. All 
these consequences may facilitate HIV in T. vaginalis-infected 
individuals.
In cases of HIV and T. vaginalis coinfection, T. vaginalis has 
been associated with increased genital shedding of HIVw10. A 
previous study showed high prevalence of T. vaginalis among 
HIV serodiscordant African couplesw11. T. vaginalis may be 
an important factor for HIV transmission in HIV discordant 
couples. Moreover, if both individuals are infected with T. vagi-
nalis as there is potential for synergistic effect, that is, increased 
genital shedding of HIV, combined with pathogenic mechanisms 
of T. vaginalis, which potentially make individuals infected with 
T. vaginalis be at a higher risk of HIV acquisition. Theoretically, 
this would increase the likelihood of HIV acquisition than when 
only one the individuals is infected with T. vaginalis.
Regarding the limitations of this review, first, most studies 
included in the review were conducted among high-risk indi-
viduals, that is, female sex workers, and serodiscordant couples. 
Thus, our result may not reflect the situation in the general popu-
lation. Second, only a couple of studies included in the review 
had male participants, but all the studies in our meta-analysis 
were based on women; our results are biased towards high-risk 
females. Third, most of the studies in the review used direct 
microscopy to detect T. vaginalis infection. Direct microscopy 
is characterised by low sensitivity, and samples detected through 
this technique usually have high parasitaemia. Although the 
few studies that used culture or NAATs for T. vaginalis detec-
tion reported positive association of T. vaginalis infection and 
increased likelihood of HIV acquisition, they also signal the need 
for further longitudinal research on this topic, evaluating if T. 
vaginalis detection techniques have an impact of this association 
Fourth, we did not assess the risk of bias that might be due to 
missing data or loss to follow-up. Finally, all studies included in 
the review were done in sSA, and thus our results may only apply 
to the sSA population.
COnClusIOn
T. vaginalis may be used as a biological marker for enhanced 
risk for HIV acquisition for both high-risk and moderate-risk 
women. T. vaginalis may be an important factor in HIV acquisi-
tion especially in sSA where the prevalence of both T. vaginalis 
and HIV is high, and this systematic review and meta-analysis 
provides consolidated evidence that infection with T. vaginalis 
augments HIV acquisition. Diagnosis and treatment of T. vagi-
nalis in both individuals at high risk and low risk for HIV may 
perhaps be a potential tool to reduce new HIV infections.
Additional references can be found in the online supplemen-
tary file 2.
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